Identity Profiling of Complex Mixtures of Peptide Products by Structural and Mass Mobility Orthogonal Analysis.
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 27 de febrero de 2023 Discovery and Optimization of Neutralizing SARS-CoV-2 Antibodies Using ALTHEA Gold Plus...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Regulatory Pathway for Licensing Biotherapeutics in Mexico. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®). VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Development and validation of a mass spectrometric method to determine the identity of rituximab based on its microheterogeneity profile....
-
UDIBI
admin_udibi3, , 2023, Sin categorizar, 0
Efficacy, Pharmacokinetics, and Toxicity Profiles of Broad Anti-SARS-CoV-2 Neutralizing Antibody. VER MÁS
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Fecha de publicación: 16 mayo de 2019 Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract Transferon®) Ver...
-
UDIBI
admin_udibi3, , Sin categorizar, 0
Validation of an ADCC assay using human primary natural killer cells to evaluate biotherapeutic products bearing an Fc región....
-
UDIBI
admin_udibi3, , Sin categorizar, 0
ALTHEA Gold Libraries™: antibody libraries for therapeutic antibody discovery. VER MÁS